@dansfera: The inside scoop on how new medicines actually hit the shelves! 🤯 For biotech investors and anyone in clinical research, this perspective shift is *essential*. Understanding the three key factors that determine an investigational product's success or failure in the FDA approval race is non-negotiable. Stop focusing on silos—the holistic approach wins the day when navigating the regulatory landscape. \#ClinicalTrials \#DrugDevelopment \#FDA \#Biotech \#MedTech